Methotrexate sodium and Eosinophilic pneumonia - a phase IV clinical study of FDA data

Summary:

Eosinophilic pneumonia is reported as a side effect among people who take Methotrexate sodium (methotrexate sodium), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Sulfamethoxazole And Trimethoprim, and have Asthma.

The phase IV clinical study analyzes which people have Eosinophilic pneumonia when taking Methotrexate sodium. It is created by eHealthMe based on reports of 96,366 people who have side effects when taking Methotrexate sodium from the FDA, and is updated regularly.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,680 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.

What is Eosinophilic pneumonia?

Eosinophilic pneumonia (eosinophil accumulates in the lung) is found to be associated with 281 drugs and 463 conditions by eHealthMe. Check the latest studies of Eosinophilic pneumonia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

96,366 people reported to have side effects when taking Methotrexate sodium.
Among them, 14 people (0.01%) have Eosinophilic pneumonia.

Could Methotrexate sodium cause Eosinophilic pneumonia?

Among these 14 people:

How long have people been on Methotrexate sodium when they have Eosinophilic pneumonia? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 100 %

What is the gender of people who have Eosinophilic pneumonia when taking Methotrexate sodium? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Eosinophilic pneumonia when taking Methotrexate sodium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 20 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 70 %

What are other drugs people take besides Methotrexate sodium? *

  1. Zoladex: 5 people, 35.71%
  2. Omnaris: 5 people, 35.71%
  3. Sulfamethoxazole And Trimethoprim: 5 people, 35.71%
  4. Calcium Disodium Versenate: 4 people, 28.57%
  5. Folate: 4 people, 28.57%
  6. Humira: 4 people, 28.57%
  7. Advair Hfa: 4 people, 28.57%
  8. Fosamax: 2 people, 14.29%
  9. Montelukast Sodium: 2 people, 14.29%
  10. Aspirin: 2 people, 14.29%

What are other side effects people have besides Eosinophilic pneumonia? *

  1. Weight Loss: 5 people, 35.71%
  2. Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 5 people, 35.71%
  3. Eosinophilic Myocarditis (acute and fulminate congestive heart failure): 5 people, 35.71%
  4. Viral Infection: 5 people, 35.71%
  5. Eosinophil Count Increased: 5 people, 35.71%
  6. Memory Loss: 5 people, 35.71%
  7. Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein): 5 people, 35.71%
  8. Nasal Polyps (masses that develop in the lining of the nose): 5 people, 35.71%
  9. Confusional State: 5 people, 35.71%
  10. Pneumonia: 5 people, 35.71%

What are the existing conditions these people have? *

  1. Asthma: 2 people, 14.29%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
  3. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 7.14%
  4. Colon Cancer Recurrent: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate sodium and have Eosinophilic pneumonia?

- Check whether Eosinophilic pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methotrexate sodium:

Eosinophilic pneumonia treatments and more:

How severe was Eosinophilic pneumonia and when was it recovered:

Expand to all the drugs that have ingredients of methotrexate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eosinophilic pneumonia:

Browse all the conditions that are associated with Eosinophilic pneumonia:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate sodium) and Methotrexate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: